Influence of liver triglycerides on suppression of glucose production by insulin in men

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 1, 2015, Pages 235-243

  Jin, Eunsook S ^a,b   Szuszkiewicz Garcia, Magdalene ^b   Browning, Jeffrey D ^a   Baxter, Jeannie D ^a,b   Abate, Nicola ^c   Malloy, Craig R ^a,b,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL; GLYCOGEN; INSULIN; TRACER; TRIACYLGLYCEROL; GLUCOSE;

ADULT; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY LIVER; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MALE; METABOLIC INHIBITION; MOLECULAR IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; BIOSYNTHESIS; DRUG EFFECTS; LIVER; METABOLISM; MIDDLE AGED; OBESITY; PHYSIOLOGY;

ADULT; FATTY LIVER; GLUCONEOGENESIS; GLUCOSE; HUMANS; INSULIN; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; OBESITY; TRIGLYCERIDES;

EID: 84920627017     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-2404     Document Type: Article

References (25)

1. Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology. 2008;134: 1369-1375.
2. Gastaldelli A, Cusi K, Pettiti M, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterol ogy. 2007;133:496-506.
3. Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA. 2009;10 6:15430-15435.
4. Stefan N,Kantartzis K,Machann J,et al. Identification and characterization of metabolically benign obesity in humans Arch Intern Med. 2008 168 1609-1616.
5. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. 2007;87: 507-520.
6. Gastaldelli A, Baldi S, Pettit i M, et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes. 2000;49:1367-1373.
7. Sunny NE, Parks EJ, Browning JD, Bu rgess SC. Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease. Cell Metab. 2011;14:804-810.
8. Karakelides H, Irving BA, Short KR, O'Bri en P, Nair KS. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes. 2010;59(1):89-97.
9. Panarotto D, Ardilouze JL, Tessier D, Maheux P. The degree of hyperinsulinemia and impaired glucose tolerance predicts plasma leptin concentrations in women only: a new exploratory paradigm. Metabolism. 2000;49(8):1055-1062.
10. Browning JD, Szc zepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40(6):1387-1395.
11. Jin ES, Burgess SC, Merritt ME, Sherry AD, Malloy CR. Differing mechanisms of hepatic glucose overproduction in triiodothyronine-treated rats vs. Zucker diabetic fatty rats by NMR analysis of plasma glucose. Am J Physiol Endocrinol Metab. 2005;288 : E654-E662.
12. Jin ES, Jones JG, Merritt M, Burgess SC, Malloy CR, Sherry AD. Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance an alysis of a single glucose derivative. Anal Biochem. 2004;327:149-155.
13. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Contributions of gluconeogenesis to gluco se production in the fasted state. J Clin Invest. 1996;98:378-385.
14. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC. Use of 2H2O for estimating rates of gluconeog enesis. Application to the fasted state. J Clin Invest. 1995;95:172-178.
15. Jones JG, Solomon MA, Cole SM, Sherry AD, Malloy CR. An integrated 2Hand 13CNMRstudy of gluconeogenesis and TCA cy cle flux in humans. Am J Physiol Endocrinol Metab. 2001;281:E848-E856.
16. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214-E223.
17. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27:1487-1495.
18. Fafournoux P, Rémésy C, DemignéC. Propionate transport in rat liver cells. Biochim Biophys Acta. 1985;818:73-80.
19. Rémésy C, DemignéC, Chartier F. Origin and utilization of volatile fatty acids in the rat. Reprod Nutr Dev. 1980;20:1339-1349.
20. Baba H, Zhang XJ, Wolfe RR. Glycerol gluconeogenesis in fasting humans. Nutrition. 1995;11:149-153.
21. Cherrin gton AD, Edgerton DS, Ramnanan CJ. The role of insulin in the regulation of PEPCK and gluconeogenesis in vivo. US Endocrinol. 2009;5(1):34-39.
22. Basu R, Chandramouli V, Dicke B, La ndau B, Rizza R. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis. Diabetes. 2005;54:1942-1948.
23. Doberne L, GreenfieldMS,Schulz B, ReavenGM.Enhanced glucose utilization during prolonged glucose clamp studies. Diabetes. 1981; 30:829-835.
24. Karelis AD, Henry JF, Malita F, et al. Comparison of insulin sensitivity values using the hyperinsulinemic euglycemic clamp: 2 vs 3 hours. Diabetes Metab. 2004;30(5):413-414.
25. Matveyenko AV,Veldhuis JD,Butler PC. Adaptations in pulsatile insulin secretion, hepatic insulin cl earance, and-cell mass to agerelated insulin resistance in rats Am J Physiol Endocrinol Metab. 2008 295 4 E832-E841.